Zobrazeno 1 - 10
of 254
pro vyhledávání: '"I-Shyan Sheen"'
Autor:
Po-Ting Lin, Wei Teng, Wen-Juei Jeng, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin, I-Shyan Sheen
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 7, Pp 788-795 (2024)
Background: Locoregional therapy and multi-kinase inhibitor agent have been the backbone of treatment for hepatocellular carcinoma (HCC) patients. However, the effect of combination or sequential use of locoregional therapy on HCC patients receiving
Externí odkaz:
https://doaj.org/article/dd0e84d5046f46e492a2131ecc45a421
Publikováno v:
Cancers, Vol 16, Iss 9, p 1739 (2024)
HCC remains one of the leading causes of cancer-related death globally. The main challenges in treatments of hepatocellular carcinoma (HCC) primarily arise from high rates of postoperative recurrence and the limited efficacy in treating advanced-stag
Externí odkaz:
https://doaj.org/article/69e6099a4ca04f94805df1f70eef9ff8
Autor:
Wei Teng, Wen‐Juei Jeng, Wei‐Ting Chen, Chen‐Chun Lin, Chun‐Yen Lin, Shi‐Ming Lin, I‐Shyan Sheen
Publikováno v:
Cancer Medicine, Vol 11, Iss 20, Pp 3786-3795 (2022)
Abstract Background A soluble form of cytotoxic‐T‐lymphocyte‐antigen‐4 (sCTLA‐4) is a prognostic biomarker for several cancers but remains unclear in HCC patients. The aim of study is to evaluate the predictive role of serum sCTLA‐4 level
Externí odkaz:
https://doaj.org/article/737e1a030570431f8bc922e7b11ddd63
Publikováno v:
Biomedical Journal, Vol 44, Iss 5, Pp 567-569 (2021)
Chronic hepatitis C, which is caused by the hepatitis C virus, represents a substantial health threat to humans and causes approximately 700,000 deaths each year worldwide. However, 30 years after the discovery of this virus in 1989, nearly perfect a
Externí odkaz:
https://doaj.org/article/2981241caf4442bfb09afea954fef0f0
Autor:
Po-Ting Lin, Wei Teng, Wen-Juei Jeng, Yi-Chung Hsieh, Chen-Fu Hung, Chien-Hao Huang, Kar-Wai Lui, Yi-Cheng Chen, Chen-Chun Lin, Shi-Ming Lin, I-Shyan Sheen, Chun-Yen Lin
Publikováno v:
Journal of the Formosan Medical Association, Vol 119, Iss 2, Pp 635-643 (2020)
Background & aims: Transarterial chemoembolization (TACE) is the standard of care for intermediate stage hepatocellular carcinoma (HCC) patients. Variceal bleeding is a life-threatening complication and may alter the initial treatment plan. This stud
Externí odkaz:
https://doaj.org/article/83109285f86d4299a374d0db7d9fe61c
Autor:
Ping-Hung Ho, Wei Teng, Chen-Chun Lin, Wen-Juei Jeng, Wei-Ting Chen, Chun-Yen Lin, Shi-Ming Lin, I-Shyan Sheen
Publikováno v:
International Journal of Hyperthermia, Vol 37, Iss 1, Pp 1008-1015 (2020)
Background The impact of prolonged post-ablation fever (PAF) defined as persistent fever > 24 h after radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) had not been described before. This study aims to investigate the impact of prolong
Externí odkaz:
https://doaj.org/article/6ef65b7382f741f3a79b07cde2dc23d1
Autor:
Ying-Chieh Chen, Wei Teng, Yi-Chung Hsieh, Wei-Ting Chen, Wen-Juei Jeng, Chien-Hao Huang, Chen-Chun Lin, Yi-Cheng Chen, Shi-Ming Lin, Chun-Yen Lin, I-Shyan Sheen
Publikováno v:
Journal of the Formosan Medical Association, Vol 118, Iss 8, Pp 1239-1246 (2019)
Background: Secondary prevention of hepatocellular carcinoma (HCC) among patients with chronic hepatitis C (CHC) who achieve sustained virologic response (SVR) with interferon-based therapy has been proved effective. However, tertiary prevention with
Externí odkaz:
https://doaj.org/article/5b70466bf2b446069902bf2e377b31e8
Publikováno v:
Cancers, Vol 14, Iss 9, p 2269 (2022)
The extended scope of upper gastrointestinal cancer can include esophageal cancer, gastric cancer and pancreatic cancer. A higher incidence rate of gastric cancer and esophageal cancer in patients with liver cirrhosis has been reported. It is attribu
Externí odkaz:
https://doaj.org/article/d7e4ce1d22144efc966d5571f8c9ffb6
Autor:
Cheng-Er Hsu, Yen-Chun Liu, Ya-Ting Cheng, Wen-Juei Jeng, Rong-Nan Chien, Chun-Yen Lin, Dar-In Tai, I-Shyan Sheen
Publikováno v:
Viruses, Vol 14, Iss 4, p 786 (2022)
Introduction: High sustained virological response (SVR) rate (>95%) and liver stiffness regression can be achieved with direct acting antivirals treatment (DAA) in patients with chronic hepatitis C virus (CHC) infection. Reactivation of hepatitis B v
Externí odkaz:
https://doaj.org/article/7fa8a4c50cf44dddb6c21cecd5a993e5
Autor:
Po-Ting Lin, Wei Teng, Wen-Juei Jeng, Wei-Ting Chen, Yi-Chung Hsieh, Chien-Hao Huang, Kar-Wai Lui, Chen-Fu Hung, Ching-Ting Wang, Pei-Mei Chai, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin, I-Shyan Sheen
Publikováno v:
Diagnostics, Vol 12, Iss 3, p 665 (2022)
Background and Aims: The Albumin-Bilirubin (ALBI) grade is a good index for liver function evaluation and is also associated with the outcomes of hepatocellular carcinoma patients receiving TACE. However, the correlation between the dynamic change to
Externí odkaz:
https://doaj.org/article/3eb35dd792b34d7392db6a0db03e7b39